Related Experiment Video
Updated: Mar 20, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Down-regulation of SIRT3 promotes ovarian carcinoma metastasis
Xue-Cai Dong1, Li-Min Jing2, Wen-Xiang Wang1
1Department of Genycologic Oncology (Section 1), Xinxiang Central Hospital, Xinxiang, Henan, PR China.
Abstract:
Distant metastasis and local recurrence are still the major causes for failure of treatment in patients with ovarian carcinoma (OC), making it urgent to further elicit the molecular mechanisms of OC metastasis. Sirtuin-3 (SIRT3), a member of the NAD(+)-dependent Class III histone deacetylases, may function as different role depending on the cell-type and tumor-type. However, the function and mechanism of SIRT3 has been not explored in OC metastasis. Here, we found that SIRT3 was significantly down-regulated in the metastatic tissues and highly metastatic cell line of ovarian cancer. In addition, knockdown of SIRT3 enhanced the migration and invasion in vitro and the liver metastasis in vivo of ovarian cancer cell. By contrast, ectopic overexpression of SIRT3 dramatically suppressed cancer cell metastatic capability. Mechanistically, SIRT3 inhibits epithelial-to-mesenchymal transition (EMT) by down-regulating Twist in ovarian cancer cells. Furthermore, an interaction between SIRT3 and Twist was detected. In conclusion, our results demonstrated that SIRT3 plays a crucial suppressive role in the metastasis of ovarian cancer by down-regulating Twist, and that this novel SIRT3/Twist axis may be valuable to develop new strategies for treating OC patients with metastasis.
Insights
Sirtuin-3 (SIRT3) suppresses ovarian cancer (OC) metastasis by down-regulating Twist. Lower SIRT3 levels enhance OC cell migration, invasion, and liver metastasis, revealing a novel SIRT3/Twist axis for therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ovarian carcinoma (OC) metastasis remains a primary cause of treatment failure.
- The role of Sirtuin-3 (SIRT3) in OC metastasis is not well understood.
- SIRT3, a histone deacetylase, has varied roles depending on cell and tumor types.
Purpose of the Study:
- To investigate the function and mechanism of SIRT3 in ovarian cancer metastasis.
- To determine the relationship between SIRT3 expression and OC metastatic potential.
- To elucidate the molecular pathway involving SIRT3 in OC metastasis.
Main Methods:
- Analysis of SIRT3 expression in metastatic OC tissues and cell lines.
- In vitro and in vivo assays to assess the impact of SIRT3 modulation on cancer cell migration, invasion, and metastasis.
- Investigation of the epithelial-to-mesenchymal transition (EMT) pathway and the role of Twist.
- Detection of the interaction between SIRT3 and Twist.
Main Results:
- SIRT3 expression was significantly downregulated in metastatic OC tissues and highly metastatic cell lines.
- SIRT3 knockdown enhanced OC cell migration, invasion, and liver metastasis.
- SIRT3 overexpression suppressed OC cell metastatic capabilities.
- SIRT3 inhibits EMT by down-regulating Twist, with a detected interaction between SIRT3 and Twist.
Conclusions:
- SIRT3 plays a critical suppressive role in ovarian cancer metastasis.
- The novel SIRT3/Twist axis regulates OC cell metastasis by inhibiting EMT.
- This SIRT3/Twist axis represents a potential therapeutic target for treating metastatic OC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
MicroRNAs
MicroRNAs

